Literature DB >> 9627244

Histopathology of human temporal bone after cis-platinum, radiation, or both.

D L Hoistad1, F G Ondrey, C Mutlu, P A Schachern, M M Paparella, G L Adams.   

Abstract

Preserving organs by use of multiple modalities has become protocol in treating squamous cell carcinomas of the head and neck, but cis-platinum and radiation can impair hearing. To determine the effect of cis-platinum, radiation, or a combination of these treatments on the temporal bone, we studied histopathologic slides of 15 human temporal bones: four after cis-platinum, five after radiation, two after combined treatment, and four from normal controls. Hair cells and cells in spiral ganglia were counted in reconstructed organs of Corti. Lumen-to-diameter indexes in arterioles near facial nerves were quantified for four normal controls and seven irradiated patients. Available audiograms were compared. Decreased spiral ganglion cells, loss of inner and outer hair cells, and atrophy of stria vascularis were demonstrated in groups receiving cis-platinum, radiation, and combinations, compared with age-matched controls. Arterioles around facial nerves demonstrated fibrinous clots within the intima, endothelial proliferation, and hypertrophy and fibrosis of vascular walls in smooth muscle. Fibrosis in connective tissue was clearly progressive after radiation. Cis-platinum and radiation can contribute to otologic sequelae, including sensorineural hearing losses, vascular changes, serous effusion, or fibrosis. Prophylactic treatments and techniques to deliver them should be considered for protection of temporal bones and preservation of hearing after oncologic modalities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627244     DOI: 10.1016/S0194-5998(98)70276-1

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  12 in total

1.  Real-time quantification of Xeroderma pigmentosum mRNA from the mammalian cochlea.

Authors:  O'neil W Guthrie; Franklin A Carrero-Martínez
Journal:  Ear Hear       Date:  2010-10       Impact factor: 3.570

2.  Preincision complex-I from the excision nuclease reaction among cochlear spiral limbus and outer hair cells.

Authors:  O'neil W Guthrie
Journal:  J Mol Histol       Date:  2008-11-01       Impact factor: 2.611

3.  Challenges of Hearing Rehabilitation after Radiation and Chemotherapy.

Authors:  Marc-Elie Nader; Paul W Gidley
Journal:  J Neurol Surg B Skull Base       Date:  2019-02-04

4.  Distortion-product otoacoustic emission test performance for ototoxicity monitoring.

Authors:  Kelly M Reavis; Garnett McMillan; Donald Austin; Frederick Gallun; Stephen A Fausti; Jane S Gordon; Wendy J Helt; Dawn Konrad-Martin
Journal:  Ear Hear       Date:  2011-02       Impact factor: 3.570

5.  Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients.

Authors:  Nicole E Marshall; Karla V Ballman; John C Michalak; Paula J Schomberg; Gary V Burton; Howard M Sandler; Terrence L Cascino; Kurt A Jaeckle; Jan C Buckner
Journal:  J Neurooncol       Date:  2006-05       Impact factor: 4.130

6.  Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors: dosimetric and audiometric aspects.

Authors:  Barbara A Jereczek-Fossa; Elena Rondi; Andrzej Zarowski; Alberto D'Onofrio; Daniela Alterio; Mario Ciocca; Livia Corinna Bianchi; Marco Krengli; Luca Calabrese; Mohssen Ansarin; Gioacchino Giugliano; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

Review 7.  Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Authors:  Jochen Schacht; Andra E Talaska; Leonard P Rybak
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

8.  Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice.

Authors:  Robert N Rainey; Sum-Yan Ng; Juan Llamas; Gijsbertus T J van der Horst; Neil Segil
Journal:  J Neurosci       Date:  2016-04-27       Impact factor: 6.167

9.  Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer.

Authors:  Johnnie K Bass; Chia-Ho Hua; Jie Huang; Arzu Onar-Thomas; Kirsten K Ness; Skye Jones; Stephanie White; Shaum P Bhagat; Kay W Chang; Thomas E Merchant
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

10.  Cochlear implantation in patients with neurofibromatosis type 2 and patients with vestibular schwannoma in the only hearing ear.

Authors:  Erika Celis-Aguilar; Luis Lassaletta; Javier Gavilán
Journal:  Int J Otolaryngol       Date:  2012-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.